Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpi Pandey

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Science (New York, N.Y.)|August 8, 2024
Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primatesFathima N Nagoor Pitchai, Elizabeth J Tanner, Neha Khetan, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Science (New York, N.Y.)|August 8, 2024
Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primatesFathima N Nagoor Pitchai, Elizabeth J Tanner, Neha Khetan, et al.
Pageof 5